SHARE

News Alert: Citius Pharmaceuticals Receives FDA Approval For LYMPHIR™ (Denileukin Diftitox-Cxdl) Immunotherapy For The Treatment Of Adults With Relapsed Or Refractory Cutaneous T-Cell Lymphoma. Click to Read More.

NuGene International Inc (OTCBB:NUGN) is aggressively executing its marketing strategies, which reflects in the company’s recent press release. The company informed its stakeholders that it had been engaged in one-on-one meetings with some of the top beauty editors in New York City. Some of the editors that the company claimed to have met includes Glamour, Vogue, Marie Claire, Allure, Shape, Self, Town and Country, Cosmopolitan, People Syle Watch, Gardens and W.

New York editors

Meanwhile, NuGene International Inc (OTCBB:NUGN) also staged its products NuGene Kathy Ireland. The company’s Sr. Director of Brand Marketing, Janine Coppola introduced the line of skin and hair care products and shared the formula innovations and distribution points. Coppola took the opportunity to introduce Dr. Dendy Engelman, who is a renowned dermatologist and a member of the company’s Advisory Board. Dr. Engelman said that the company’s stem cells are taken from fatty tissue known as adipose of healthy donors.

She explained that adipose is an effective solution to aging and other skin signs. Dr. Engelman also disclosed the results of a 12-week split face study that displayed the vast improvement in the skin of the subjects. The before and after photos showed visible changes in the subjects, who acknowledged the reduced hyperpigmentation and reduction in wrinkles.

On e-commerce site

It is unarguable that NuGene International Inc (OTCBB:NUGN)’s is impressively exhibiting its marketing strategies, which is also fetching it results. The company recently announced that its Kathy Ireland product has been chosen as a premier range of products by the LovelySkin.com, a skin based e-commerce company. The significance of such news grows higher based on the fact that the e-commerce is owned by a premier dermatologist, which attests the genuineness of the company’s products.

The stock of NuGene International Inc (OTCBB:NUGN) closed 2.27% higher at $3.60 during the previous trading session as 857,000 shares changed hands.